MARAVAI LIFESCIENCES HOLDINGS, INC.

Insiders Maravai LifeSciences Holdings, Inc.

Equities

MRVI

US56600D1072

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
10.46 ^USD	+6.09%		+16.61%	+59.69%

05-09	UBS Raises Price Target on Maravai LifeSciences to $8.50 From $6.50, Maintains Neutral Rating	MT
05-09	Baird Adjusts Price Target on Maravai LifeSciences to $10 From $8, Keeps Outperform Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Maravai LifeSciences' New CEO William Martin Takes Helm	28/07/23	MT
Maravai Lifesciences Holdings, Inc. Appoints William Trey Martin as Chief Executive Officer	27/07/23	CI
Maravai LifeSciences Holdings, Inc. Announces Board Changes	20/07/23	CI
Maravai Lifesciences Holdings, Inc. Announces Executive Changes	13/03/23	CI
Maravai LifeSciences Names William Martin III President of Biologics Safety Testing Unit, to Resume CEO Role in July	01/12/22	MT
Maravai LifeSciences Holdings, Inc. Announces William “Trey” Martin, III to serve as President of Maravai’s Biologics Safety Testing Segment, Effective December 5, 2022	01/12/22	CI
Maravai LifeSciences Holdings, Inc. Announces Executive Changes	01/12/22	CI
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500 List of Fastest-Growing Companies in North America - November 16, 2022	17/11/22	AQ
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America	16/11/22	GL
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America	16/11/22	AQ
Maravai LifeSciences Reinstates Carl Hull as Interim CEO Amid Ongoing Noncompetition Litigation	19/10/22	MT
Maravai Lifesciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation	19/10/22	CI
Maravai LifeSciences Holdings Appoints William Martin as CEO; Shares Plunge	04/10/22	MT
Maravai LifeSciences Holdings Appoints William Martin as CEO	03/10/22	MT
Maravai LifeSciences Announces CEO Leadership Transition	03/10/22	CI
Maravai LifeSciences, Inc. Appoints Peter Leddy as Executive Vice President and Chief Administrative Officer	27/06/22	CI
Eric Tardif Plans to Retire as President of Maravai LifeSciences Holdings, Inc., Effective as of June 30, 2021	20/05/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer